Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1807)	1/16/1998 10:38:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 7041

Bill: I do not hold a position in ZONA but hold long-term positions in several Big Pharma stocks including PFE, MRK,WLA and LLY and a recent position in VVUS (@10). What strikes me about your posts is their repetition (very boring) and your insistence that you are 100% correct and everyone else is crazy. Trust me life is not that simple. At the very least, there is a possibility that Vasomax is a potential NDA product. It is doubtful that ZONA and SGP will not attempt to submit this product to the FDA. Moreover, there is a real possibility that this submission could come in the first quarter. Why? Viagra was given a 6 month priority review by the FDA.... which must inform Pfizer of the NDA status by March or April of 1998. Zonagen is under the impression that if they make their submission prior to the Viagra approval, Vasomax will also receive NDA priority review. If this scenario happens, short positions in ZONA will be in deep trouble. Although I am very long with Zonagen's primary competitor, it is a real pleasure to know that fact-twisting, unethical Manuel Asensio is sweating this long holiday weekend about his ZONA holdings. BigKNY3